INVESTOR RELATIONS
Investor relations (NASDAQ)
Stock Information
Corporate Governance
Events & Presentations
Financials & Filings
Investor Resources
Email Alerts
News and Media
Investor relations (HKEX)
CONTACT US
中文
WHO WE ARE
ABOUT Zai Lab
EXECUTIVE TEAM
BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD
OUR MISSION
SUSTAINABILITY
WHAT WE DO
DISCOVERY
DEVELOPMENT
MANUFACTURING
COMMERCIALIZATION
PARTNERING
OUR R&D
PIPELINE
SELECTED ONGOING CLINICAL TRIALS
PRODUCTS
CAREERS
WORKING AT Zai Lab
JOIN US
NEWS
PRESS RELEASE
PARTNER NEWS
MEDIA REPORTS
Back to Pipeline
Odronextamab (CD20xCD3)
Prev:
Adagrasib (KRAS G12C)
Repotrectinib (ROS1, TRK)
:Next
